Your browser doesn't support javascript.
loading
Mechanisms of losartan for inhibition of myocardial fibrosis following myocardial infarction in rats / 南方医科大学学报
Artigo em Chinês | WPRIM (Pacífico Ocidental) | ID: wpr-339085
Biblioteca responsável: WPRO
ABSTRACT
<p><b>OBJECTIVE</b>To investigate the effect of losartan on cardiac mineralocorticoid receptor (MR) mRNA in rats after acute myocardial infarction (AMI).</p><p><b>METHOD</b>AMI was induced in male SD rats by ligation of the left coronary artery. The survived rats were randomly divided into AMI group, losartan group, and sham-operated group. The cardiac functions of the rats were assessed by echocardiogram and hemodynamics, and the contents of angiotensin II (Ang II) and aldosterone (Ald) in the myocardial tissues were determined by radioimmunoassay. The collagen density in the myocardial tissues were calculated by Masson's trichrome staining and the expression of MR mRNA were determined by real-time quantitative fluorescent PCR.</p><p><b>RESULTS</b>Both the contents of AngII and Ald in the myocardial tissues increased significantly in AMI group compared with those in the sham-operated group (P<0.01). The expression of MR mRNA and collagen density in the myocardial tissues also increased significantly than that in sham-operated group (P<0.01). After four weeks of losartan treatment, the contents of AngII and Ald in the myocardial tissues decreased significantly (P<0.05) and the expression of MR mRNA was also considerably lowered (P<0.01) in comparison with those in the AMI group. Treatment with losartan also resulted in significant decrease of the collagen density in the myocardial tissues.</p><p><b>CONCLUSIONS</b>Losartan may reduce reactive fibrosis not only by attenuating the Ald signaling pathway but also by decreasing the expression of MR.</p>
Assuntos
Texto completo: Disponível Base de dados: WPRIM (Pacífico Ocidental) Assunto principal: Patologia / Fibrose / RNA Mensageiro / Angiotensina II / Distribuição Aleatória / Ratos Sprague-Dawley / Receptores de Mineralocorticoides / Losartan / Usos Terapêuticos / Bloqueadores do Receptor Tipo 1 de Angiotensina II Limite: Animais Idioma: Chinês Revista: Journal of Southern Medical University Ano de publicação: 2008 Tipo de documento: Artigo
Texto completo: Disponível Base de dados: WPRIM (Pacífico Ocidental) Assunto principal: Patologia / Fibrose / RNA Mensageiro / Angiotensina II / Distribuição Aleatória / Ratos Sprague-Dawley / Receptores de Mineralocorticoides / Losartan / Usos Terapêuticos / Bloqueadores do Receptor Tipo 1 de Angiotensina II Limite: Animais Idioma: Chinês Revista: Journal of Southern Medical University Ano de publicação: 2008 Tipo de documento: Artigo
...